Celanese Corporation (NYSE:CE) Files An 8-K Other EventsItem 8.01 Other Events.
The Company announced that to ease the path of index funds to ownership of the Company’s common stock, the Board of Directors has voted to propose for stockholder approval an amendment to the Company’s certificate of incorporation to eliminate the authorization of Series B Common Stock and to rename the outstanding shares of Series A Common Stock as merely “Common Stock.” All shares of Series B Common Stock outstanding on April 7, 2005 were converted into Series A Common Stock. Under the certificate of incorporation, upon the conversion of the Series B shares, such shares were cancelled and may not be reissued. No new shares of Series B Common Stock have been issued since the date of the conversion and the Company has no intent of issuing any shares of Series B Common Stock prior to the planned amendment. The rights, powers, preferences and privileges of the outstanding shares of the Company’s Series A Common Stock would not be affected by the proposed amendment.
About Celanese Corporation (NYSE:CE)
Celanese Corporation (Celanese) is a technology and specialty materials company. The Company operates through four segments: Advanced Engineered Materials, Consumer Specialties, Industrial Specialties and Acetyl Intermediates. Its business involves processing chemical raw materials, such as methanol, carbon monoxide, ethylene and natural products, including wood pulp, into chemicals, thermoplastic polymers and other chemical-based products. It engineers and manufactures a range of products, which serves a range of end-use applications, including paints and coatings, textiles, automotive applications, consumer and medical applications, performance industrial applications, filtration applications, paper and packaging, chemical additives, construction, consumer and industrial adhesives, and food and beverage applications. The Company operates in North America, Europe and Asia and consists of approximately 20 global production facilities.
